Clinical Trial Update: Safety and Efficacy of Dexamethasone Ophthalmic Insert (Dextenza®) in the Management of Clinically Significant Dry Eye [Phase 4]

View source ↗

Summary

Phase 4 trial update on dexamethasone ophthalmic insert (Dextenza) for clinically significant dry eye; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye

Drugs mentioned

• Dextenza (Dexamethasone)

Snippet

Sponsor: Johns Hopkins University | Conditions: Dry Eye | Phase 4 | Status: TERMINATED | Results posted: 2024-03-15